The global anti-infective vaccines market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The growing incidences of bacterial as well as viral diseases coupled with increased focus on immunization programs are the primary factors that are likely to boost the global anti-infectives vaccines market growth in the future years. Furthermore, the growing activities related to the vaccine R&D, coupled with the increased government support for vaccine advancement, are also likely to boost the global market growth during the forecast period. The rising government initiatives with an objective to raise awareness about the benefits of vaccination and preventing the spread of communicable illnesses that are linked with high morbidity are the pivotal drivers of the global anti-infective vaccines market. For instance, the ‘Immunize Australia Program’ funds individual immunization serves as a preventative approach in reducing and limiting diseases transmission, thus preventing millions of Australians from serious diseases. 

Apart from the increasing role of government organizations, the non-government organizations creating global awareness that is also further boosting the global anti-infective vaccines market. UNICEF and the WHO have released guidelines for developing a national immunization plan, known as the Comprehensive Multi-Year Plan (cMYP), for all countries around the world, with the goal of ensuring equitable access to vaccination facilities for all people and increasing stakeholder participation in meeting vaccination coverage targets by designing and implementing feasible financial strategies.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Product Type
• By Disease Type
• By Distribution Channel 

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Evotec SE, Merck & Co., Inc., and GlaxoSmithKline plc, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti-Infective Vaccines Market Report by Segment

By Product Type

• Live/Attenuated Vaccines
•  Inactivated Vaccines
• DNA & Recombinant Vector Vaccines
• Others

By Disease Type

• Bacterial Diseases

o Typhoid Vaccines

o Tuberculosis Vaccines

o Tetanus & Diphtheria Vaccines

o Others

• Viral Diseases

o Influenza Vaccines

o Hepatitis Vaccines

o Polio Vaccines

o Others

By Distribution Channel

• Hospitals
• Clinics
• Others

Global Anti-Infective Vaccines Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa